Table 3 Reported outcomes – visual analogue scale (VAS) following intraarticular injection of autologous conditioned serum/autologous protein solution (ACS/APS)
Author and year | Study patients | Age at presentation Mean (± SD)/median (range) | Follow-up (months) Mean (± SD)/median (range) | Outcome measure | Baseline | Post procedure | |
|---|---|---|---|---|---|---|---|
Score Mean (± SD)/median (range) | Time point(s) (weeks/months) | Score Mean (± SD)/median (range) | |||||
Kon et al. 2018 [22] | 46 | 57 (41–68) | 12 (± NR) | VAS | 5.5 (± NR) | 12 months | NRa |
Tassara et al. 2018 [24] | 25 | 68 (34–87) | 6 (± NR) | VAS | 80 (70–100) | 1 month | 20 (0–60) |
6 months | 20 (0–60) | ||||||
100 | 61.2 (± 1.2) | 12 (± NR) | VAS | 5.8 (± 0.6) | 1 week | 4.2 (± NR) | |
2 weeks | 3.3 (± NR) | ||||||
3 months | 3.1 (± NR) | ||||||
6 months | 3.2 (± NR) | ||||||
12 months | 2.3 (± NR) | ||||||
Hang et al. 2017 | 92 | NR | 12 (± NR) | VAS | 6.07 (± NR) | 12 months | 2.52 (± NR) |
Shirokova et al. 2017 [34] | 123 | 59.9 (± 8.8) | 3 (± NR) | VAS | NRb | 3 months | NRb |
Rutgers et al. 2015 [36] | 20 | 50 (34–70) | 12 (± NR) | VAS | 52.20 (± 22.90) | 12 months | 50.05 (± 23.76) |
Baltzer et al. 2009 [38] | 376 | 53.8 (± 12.2) | 25 (± NR) | VAS | 69.6 (± 13.10) | 6 months | 29.5 (± 22.58) |